Characteristics of intussusception in the period of arbitrary Rotavirus vaccination.
hydrostatic contrast enema
intussusception
rotavirus
vaccine
Journal
Pediatrics international : official journal of the Japan Pediatric Society
ISSN: 1442-200X
Titre abrégé: Pediatr Int
Pays: Australia
ID NLM: 100886002
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
revised:
21
07
2022
received:
04
03
2022
accepted:
16
08
2022
pubmed:
24
9
2022
medline:
4
11
2022
entrez:
23
9
2022
Statut:
ppublish
Résumé
In November 2011, rotavirus (RV) vaccine was launched in Japan as a voluntary vaccination to prevent RV-associated gastroenterocolitis. We examined the characteristics of intussusception following RV vaccination in our two centers. We investigated intussusception patients <16 years old from January 2006 to September 2020. Patients were categorized according to the period (before [Group A] or after the introduction of arbitrary RV vaccination [Group B]). The patient characteristics and treatment of intussusception were retrospectively investigated. During the study period, 560 patients (group A, n = 233; group B, n = 327) were identified. The distribution of patients who were 0-6 months old was not significantly different between the groups (group A, n = 12, 5.2%; group B, n = 18, 5.5%). Among these 18 patients in Group B, 7 were vaccinated against RV, and 10 were not. One patient was excluded due to incomplete data. On comparing patients with and without RV vaccination, the mean age at the onset of intussusception was 3.3 ± 0.4 versus 4.0 ± 0.3 months (P = 0.19), the mean interval from the onset to treatment was 7.5 ± 2.4 versus 16.0 ± 2.2 h (P = 0.03), the time of the contrast enema for treatment was 9.1 ± 3.3 versus 7.7 ± 2.8 min (P = 0.76), and the final pressure of the contrast enema was 92.5 ± 4.4 versus 92.2 ± 4.4 cmH Arbitrary RV vaccination did not influence the age distribution of intussusception, and the interval from the onset to treatment was significantly shorter in the patients with RV vaccination than in those without it. Recognizing the presence of intussusception following RV vaccination enables accurate treatment.
Sections du résumé
BACKGROUND
BACKGROUND
In November 2011, rotavirus (RV) vaccine was launched in Japan as a voluntary vaccination to prevent RV-associated gastroenterocolitis. We examined the characteristics of intussusception following RV vaccination in our two centers.
METHODS
METHODS
We investigated intussusception patients <16 years old from January 2006 to September 2020. Patients were categorized according to the period (before [Group A] or after the introduction of arbitrary RV vaccination [Group B]). The patient characteristics and treatment of intussusception were retrospectively investigated.
RESULTS
RESULTS
During the study period, 560 patients (group A, n = 233; group B, n = 327) were identified. The distribution of patients who were 0-6 months old was not significantly different between the groups (group A, n = 12, 5.2%; group B, n = 18, 5.5%). Among these 18 patients in Group B, 7 were vaccinated against RV, and 10 were not. One patient was excluded due to incomplete data. On comparing patients with and without RV vaccination, the mean age at the onset of intussusception was 3.3 ± 0.4 versus 4.0 ± 0.3 months (P = 0.19), the mean interval from the onset to treatment was 7.5 ± 2.4 versus 16.0 ± 2.2 h (P = 0.03), the time of the contrast enema for treatment was 9.1 ± 3.3 versus 7.7 ± 2.8 min (P = 0.76), and the final pressure of the contrast enema was 92.5 ± 4.4 versus 92.2 ± 4.4 cmH
CONCLUSIONS
CONCLUSIONS
Arbitrary RV vaccination did not influence the age distribution of intussusception, and the interval from the onset to treatment was significantly shorter in the patients with RV vaccination than in those without it. Recognizing the presence of intussusception following RV vaccination enables accurate treatment.
Substances chimiques
Rotavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15332Informations de copyright
© 2022 Japan Pediatric Society.
Références
Glass RI, Parashar UD, Bresee JS et al. Rotavirus vaccines: Current prospects and future challenges. Lancet 2006; 368: 323-32.
Tate JE, Burton AH, Boschi-Pinto C et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect. Dis. 2012; 12 (2): 136-41.
Parashar UD, Bresee JS, Gentsch JR, Glass RI. Rotavirus. Emerg. Infect. Dis. 1998; 4: 561-70.
Parashar U, Gibson CJ, Bresee JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis. 2005; 12: 304-6.
Ushijima H. Rotavirus vaccine. J. Japan Med. Assoc. 2009; 136: 701-4.
Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD. Intussusception and rotavirus vaccination: A review of the available evidence. Expert Rev. Vaccines 2009; 8 (11): 1555-64.
Murphy TV, Gargiullo PM, Massoudi MS et al. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 2001; 344: 564-72.
Penina H, Manish P, Yi P et al. Intussusception after rotavirus vaccines reported to US Vaers, 2006-2012. Pediatrics 2013; 131 (6): 1042-9.
Tsugawa T, Akane Y, Honjo S, Kondo K, Kawasaki Y. Rotavirus vaccination in Japan: Efficacy and safety of vaccines, changes in genotype, and surveillance efforts. J. Infect. Chemother. 2021; 27: 940-8.
Mandeville K, Chien M, Willyerd FA, Mandell G, Hostetler MA, Bulloch B. Intussusception: Clinical presentations and imaging characteristics. Pediatr. Emerg. Care 2012; 28: 842-4.
Aboagye J, Goldstein SD, Salazar JH et al. Age at presentation of common pediatric surgical conditions: Reexamining dogma. J. Pediatr. Surg. 2014; 49: 995-9.
Vincent B, Lionel VH, Olivia M, Katsiaryna H, Keiji S, Hubert B. Post-marketing monitoring of intussusception after rotavirus vaccination in Japan. Pharmacoepidemiol. Drug Saf. 2015; 24: 765-70.
Hai-Ling L, Ding Y, Goyal H, Hua-Guo X. Association between rotavirus vaccination and risk of intussusception among neonates and infants: A systematic review and meta-analysis. JAMA Netw. Open 2019; 2: e1912458.
Takahashi Y, Souzaki R, Nagata K, Hayashida M, Taguchi T. Clinical features of intussusception in children over a decade: Experience in a single institution. J. Jpn. Soc. Pediatr. Surg. 2013; 49: 904-8.
Alexandre CL, Velazquez FR, Irene PS et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life Latin American infants: A randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371 (9619): 1181-9.
Zlamy M, Kofler S, Orth D et al. The impact of rotavirus mass vaccination on hospitalization rates, nosocomial rotavirus gastroenteritis and secondary blood stream infections. BMC Infect. Dis. 2013; 13: 112.
Ministry of Health, Labour and Welfare. [cited 2017 June 30]. Available from URL: http://www.mhlw.go.jp/file/05-shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000125185.pdf
Oishi T, Taguchi T, Nakano T, Sudo S, Kuwajima H. The occurrence of severe rotavirus gastroenteritis in children under 3 years of age before and after the introduction of rotavirus vaccine: A prospective observational study in three pediatric clinics in Shibata City, Niigata prefecture, Japan. Jpn. J. Infect. Dis. 2014; 67: 304-6.
Oishi T, Tsukano S, Nakano T, Sudo S, Kuwajima H, Shibata RVGE Study Group. Impact of rotavirus vaccination in severe rotavirus gastroenteritis outpatient visits at three pediatric primary care clinics in Shibata city, Niigata prefecture, Japan. Open J. Pediatr. 2014; 04: 291-9.
Yoshimaru K, Kinoshita Y, Matsuura T et al. Clinical analysis of 70 bowel obstruction cases without a history of laparotomy. Pediatr. Int. 2016; 58 (11): 1205-10.
Yanagita Y, Yatabe K, Hara T, Yoshida P. Investigation of the occurrence of intussusception after administration of oral live attenuated human vaccine (Rotarix®): Result from special drug use investigation. Prog. Med. 2016; 36: 1121-5.
Miura M, Sato K, Muto H, Gopala K, Holl K. Intussusception in Japanese infants: Analysis of health insurance claims database. Open J. Pediatr. 2013; 3: 311-6.
Higashio A, Takama Y, Santo K, Nakaoka T, Yoneda A, Nakamura T. An enterectomy case of intussusception after rotavirus vaccination. J. Jpn. Soc. Pediatr. Surg. 2017; 53: 272-6.
Ledent E, Liftucht A, Buyse H, Sugiyama K, Mclenna M, Holl K. Post-marketing benefit-risk assessment of rotavirus vaccination in Japan: A simulation and modelling analysis. Drug Saf. 2016; 39: 219-30.